Analysis of a new extension version of the exponential model using improved adaptive progressive censored data and its applications.

This article covers the issue of evaluating the two shape parameters and reliability metrics of a novel Kumaraswamy-exponential lifetime distribution, whose density exhibits a left-skewed, right-skewed, or symmetric shape, through a type-II improved adaptive progressively censored sample. Both conventional and Bayesian viewpoints are used to evaluate the various parameters, which include point and interval estimations. While the estimation of one of the shape parameters requires a numerical solution, the other shape parameter estimation can be carried out in closed form by the classical method. Besides, the likelihood method's asymptotic traits are employed to provide interval estimations for all parameters. Leveraging the Markov chain Monte Carlo process, the symmetric squared loss function and independent gamma priors are taken into account for calculating Bayes points and the highest posterior density interval estimations. To illustrate the accuracy, compare estimation methods, and show the applicability of the various suggested methods, a simulation examination and a pair of applications are looked at. In the end, four accuracy indicators are taken into consideration to figure out the best progressive censoring pattern. The numerical results indicate that when collecting samples using the suggested censored procedure, it is advisable to use the Bayesian estimation approach for evaluating the Kumaraswamy-exponential distribution. [ABSTRACT FROM AUTHOR]

Copyright of AIP Advances is the property of American Institute of Physics and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)